Nutritional compositions containing synergistic combination and uses thereof
A composition and method for enhancing brain development in a pediatric subject, the method including administering to the pediatric subject a nutritional composition having up to about 7 g/100 kcal of a fat or lipid source, wherein the fat or lipid source includes at least about 0.5 mg/100 kcal of milk or non-milk polar lipids; up to about 5 g/100 kcal of a protein source; at least about 15 mg/100 kcal of lactoferrin from a non-human source; about 0.015 g/100 kcal to about 0.15 g/100 kcal of a prebiotic composition including polydextrose and/or galactooligosaccharide; and at least about 5 mg/100 kcal of a source of long chain polyunsaturated fatty acids.
1. A method for enhancing brain development in a pediatric subject, the method comprising administering to the pediatric subject a nutritional composition comprising:
a. up to about 7 g/100 kcal of a fat or lipid source, wherein the fat or lipid source comprises at least about 0.5 mg/100 kcal polar lipids, wherein the polar lipids comprise gangliosides and phospholipids, and further wherein the gangliosides are present at a level of about 0.5 mg/100 kcal to about 18 mg/100 kcal, and the phospholipids are present at a level of about 20 mg/100 kcal to about 250 mg/100 kcal;
b. up to about 5 g/100 kcal of a protein source;
c. at least about 15 mg/100 kcal of lactoferrin from a non-human source;
d. a prebiotic composition, wherein at least 20% of the prebiotic composition comprises polydextrose, galactooligosaccharide or a combination thereof;
e. at least about 5 mg/100 kcal of a source of long chain polyunsaturated fatty acids comprising docosahexaenoic acid; and
f. a preservative.
2. The method of claim 1 , wherein the polar lipids are present at a level of about 0.5 mg/100 kcal to about 470 mg/100 kcal.
3. The method of claim 2 , wherein the polar lipids are present at a level of about 10 mg/100 kcal to about 350 mg/100 kcal.
4. The method of claim 3 , wherein the polar lipids are present at a level of about 20 mg/100 kcal to about 260 mg/100 kcal.
5. The method of claim 1 , wherein lactoferrin is present at a level of about 10 mg/100 kcal to about 200 mg/100 kcal.
6. The method of claim 5 , wherein the lactoferrin is bovine lactoferrin.
7. The method of claim 1 , wherein the source of long chain polyunsaturated fatty acids is present more preferably from about 5 mg/100 kcal to about 75 mg/100 kcal.
8. The method of claim 1 , wherein the nutritional composition is an infant formula or a growing up milk.
9. A nutritional composition for enhancing brain development in a pediatric subject, comprising:
a. up to about 7 g/100 kcal of a fat or lipid source, wherein the fat or lipid source comprises at least about 0.5 mg/100 kcal polar lipids, wherein the polar lipids comprise gangliosides and phospholipids, and further wherein the gangliosides are present at a level of about 0.5 mg/100 kcal to about 18 mg/100 kcal, and the phospholipids are present at a level of about 20 mg/100 kcal to about 250 mg/100 kcal;
b. up to about 5 g/100 kcal of a protein source;
c. at least about 15 mg/100 kcal of lactoferrin from a non-human source;
d. a prebiotic composition, wherein at least 20% of the prebiotic composition comprises polydextrose, galactooligosaccharide or a combination thereof;
e. at least about 5 mg/100 kcal of a source of long chain polyunsaturated fatty acids comprising docosahexaenoic acid; and
f. a preservative.
10. The composition of claim 9 , wherein the polar lipids are present at a level of about 0.5 mg/100 kcal to about 470 mg/100 kcal.
11. The composition of claim 10 , wherein the polar lipids are present at a level of about 10 mg/100 kcal to about 350 mg/100 kcal.
12. The composition of claim 11 , wherein the polar lipids are present at a level of about 20 mg/100 kcal to about 260 mg/100 kcal.
13. The composition of claim 9 , wherein lactoferrin is present at a level of about 15 mg/100 kcal to about 300 mg/100 kcal.
14. The composition of claim 13 , wherein the lactoferrin is bovine lactoferrin.
15. The composition of claim 9 , wherein the source of long chain polyunsaturated fatty acids is present more preferably from about 5 mg/100 kcal to about 75 mg/100 kcal.
16. The composition of claim 9 , wherein the nutritional composition is an infant formula or a growing up milk.
17. The method of claim 1 , wherein the prebiotic composition is present in the nutritional composition from about 1.0 g/L to about 10.0 g/L.
18. The composition of claim 9 , wherein the prebiotic composition is present from about 1.0 g/L to about 10.0 g/L.
19. The method of claim 1 , wherein the pediatric subject is an infant and further wherein the gangliosides are present at a level of about 0.5 mg/100 kcal to about 12 mg/100 kcal and the phospholipids are present at a level of about 20 mg/100 kcal to about 50 mg/100 kcal.
20. The method of claim 1 , wherein the pediatric subject is an infant between birth and 6 months of age, and further wherein the gangliosides are present at a level of about 0.5 mg/100 kcal to about 9 mg/100 kcal and the phospholipids are present at a level of about 20 mg/100 kcal to about 150 mg/100 kcal.